Print

IAVI C002

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the ADMVA vaccine administered three times, intramuscularly at 3 dosage levels

Trial Details:

I Completed
IAVI Aaron Diamond AIDS Research Center University of Rochester January 01, 2005
ADMVA env/gag-pol and nef-tat C
ADMVA Viral Vector - Pox
USA 48
NCT00252148
http://www.adarc.org/ http://www.clinicaltrials.gov/ct2/show/NCT00252148?term=C002&rank=1